The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has successfully closed the acquisition of the French company Polyplus. The transaction was completed today, after receiving the required regulatory approvals. Polyplus is a leading provider of innovative technologies for cell and gene therapies. Transfection reagents developed and produced by Polyplus are […]
Danaher Corporation has announced today the completion of the sale of some of its businesses to Sartorius AG for a consideration of $825 million. The sale was a requirement in order to obtain regulatory approval for Danaher’s acquisition of the GE Biopharma business, now called Cytiva. The sale included its label-free biomolecular characterization, chromatography hardware […]
Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industry, today has signed a contract to acquire U.S. centrifuge specialist kSep Holdings, Inc. (kSep). The privately owned company based in Morrisville, North Carolina, has been operating on the market since 2011, and is expected to achieve significant double-digit growth and to generate around […]